Explain this page
Arphra AIPlain-English read on Terns Pharmaceuticals, Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$8.43
-84.07% vs spot
Recommendation
Sell
3 of 3 methods
Method spread
0bull3bear
±5% threshold
Analyst PT consensus: $55.50 (+4.82%)
Candlestick · 1Y
Open in chart workstation →TERN
52.95+1297.10%H 53.19L 3.66MA50 50.16MA200 28.69Avg vol 3.3M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | +13.82% | +17.67% | +31.06% | +1220.45% | +349.87% | +247.21% | +187.93% | +187.93% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$52.95
Bid
$38.13
2 sh
Ask
$67.80
2 sh
Spread
$29.670
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 Dec 2025 | $0 | -$23.57M | $-0.24 |
| Q3 Sep 2025 | $0 | -$24.64M | $-0.27 |
| Q2 Jun 2025 | $0 | -$24.09M | $-0.26 |
| Q1 Mar 2025 | $0 | -$23.91M | $-0.26 |
| Q4 Dec 2024 | $0 | -$21.8M | $-0.24 |
| Q3 Sep 2024 | $0 | -$21.95M | $-0.28 |
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for TERN.
Peers
No peer list available for TERN.
Total assets
$1.03B
Total debt
$919K
Cash & equiv
$524.75M
Operating CF
-$82.18M
Free cash flow
-$82.18M
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $0 | -$110.12M | -$96.21M | $-1.03 | — |
| FY 2024 | $0 | -$101.87M | -$88.85M | $-1.12 | — |
| FY 2023 | $0 | -$102.56M | -$90.21M | $-1.27 | — |
| FY 2022 | $0 | -$62.03M | -$60.35M | $-1.67 | — |
| FY 2021 | $1M | -$49.86M | -$50.16M | $-1.98 | -5015.80% |